Evidence map›Paper›PMID 34708888›Full record

ArticleJournal of clinical laboratory analysis2021

Association between serum lactate dehydrogenase and 60-day mortality in Chinese Hakka patients with acute myeloid leukemia: A cohort study.

Zuomiao Xiao, Rongpeng Gong, Xianchun Chen, Dejun Xiao, Shi Luo, Yanhong Ji

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Zuomiao XiaoDepartment of Clinical Laboratory, The Affiliated Ganzhou Hospital of Nanchang University, Ganzhou, China.ORCID https://orcid.org/0000-0002-6852-3372
Rongpeng GongMedical College of Qinghai University, Xining, China.
Xianchun ChenDepartment of Clinical Laboratory, The Affiliated Ganzhou Hospital of Nanchang University, Ganzhou, China.
Dejun XiaoDepartment of Clinical Laboratory, The Affiliated Ganzhou Hospital of Nanchang University, Ganzhou, China.
Shi LuoDepartment of Clinical Laboratory, The Affiliated Ganzhou Hospital of Nanchang University, Ganzhou, China.
Yanhong JiDepartment of Immunology& Microbiology, School of Medicine, Xi'an Jiaotong University, Xi'an Shaanxi, China.
Nanchang University · CNQinghai University · CNXi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is evidence that a high level of serum lactate dehydrogenase (LDH) is associated with poorer overall survival in acute myeloid leukemia (AML), but its link to 60-day mortality of AML remains unclear.

methodsAll patients newly diagnosed with AML were included in this cohort study. LDH was measured for the first time after admission. Multivariable logistic regression was used to explore the association between serum LDH and 60-day mortality. Interaction and stratified analyses were conducted including age, sex, albumin, glucose, myoglobin, and standard chemotherapy.

resultsThree hundred and seventy-one patients ≥15 years of age, who were newly diagnosed with AML, were consecutively selected. The total prevalence of 60-day mortality was 27.2% (101/371), while it was 32.1% (42/131) and higher than in the LDH ≥570U/L compared with the LDH<570U/L, with the prevalence of 24.6% (59/240); however, the difference was not statistically significant. In multivariate regression models, odd ratios and corresponding 95% confidence intervals (CIs) for Log

conclusionsSerum LDH level was associated with 60-day mortality, especially for the patients with LDH ≥570U/L.

Indexed as

AdolescentAdultAgedAged, 80 and overAsian PeopleBiomarkers, TumorChinaFemaleHumansLeukemia, Myeloid, AcuteL-Lactate DehydrogenaseLogistic ModelsMaleMiddle AgedYoung AdultBiomarkers, TumorL-Lactate Dehydrogenase60-day mortalityacute myeloid leukemia (AML)lactate dehydrogenase (LDH)

Identifiers

PMID34708888
PMCPMC8649362
OpenAlexW3210917592

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.